PainReform Ltd. (NASDAQ: PRFX)
$0.53
-0.0186 ( -3.41% ) 63.4K
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Market Data
Open
$0.53
Previous close
$0.55
Volume
63.4K
Market cap
$1.87M
Day range
$0.52 - $0.57
52 week range
$0.43 - $11.55
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Mar 01, 2024 |
20-f | Annual reports | 66 | Feb 29, 2024 |
6-k | Quarterly Reports | 3 | Jan 03, 2024 |
6-k | Quarterly Reports | 4 | Dec 27, 2023 |
6-k | Quarterly Reports | 3 | Dec 27, 2023 |
6-k | Quarterly Reports | 6 | Nov 15, 2023 |
6-k | Quarterly Reports | 3 | Sep 11, 2023 |
6-k | Quarterly Reports | 41 | Aug 10, 2023 |
6-k | Quarterly Reports | 3 | Jul 19, 2023 |
6-k | Quarterly Reports | 9 | Jul 18, 2023 |